First National Corp’s Biogen BIIB Stock Holding History

First National Corp’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-508	Closed	-$120K	–	168
2019 Q1	$120K	Hold	508	–	–	0.05%	161
2018 Q4	$153K	Buy	+508	New	+$162K	0.07%	151

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First National Corp's BIIB Position: Q2 2019 in Review

First National Corp sold out of Biogen (BIIB) in Q2 2019, closing a stake of 508 shares — an estimated $120K sold.

First National Corp first reported a position in BIIB in Q4 2018 and held it in 2 quarters. The position peaked at $153K in Q4 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

First National Corp reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
First National Corp sold 508 Biogen shares in Q2 2019, an estimated $120K.
First National Corp first reported a position in Biogen in Q4 2018 and held it in 2 quarters.
First National Corp's Biogen position peaked at $153K in Q4 2018.
1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on First National Corp's 13F filing for Q2 2019, filed 30 Jul 2019.